Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
10x Genomics, Inc. (TXG) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2023 8-K Quarterly results
Docs: "10x Genomics Reports Second Quarter 2023 Financial Results"
07/21/2023 144 Form 144 - Report of proposed sale of securities:
07/20/2023 8-K Quarterly results
07/10/2023 SC 13G/A MORGAN STANLEY reports a 5.2% stake in 10x Genomics, Inc.
07/10/2023 SC 13G/A FMR LLC reports a 12.7% stake in 10X GENOMICS INC
06/16/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/17/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "10x Genomics Wins Permanent Injunction Against NanoString’s CosMx Products 10x Genomics is seeking additional injunctions to protect its intellectual property"
05/11/2023 144 Form 144 - Report of proposed sale of securities:
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
02/14/2023 SC 13G/A Venrock Associates VI, L.P. reports a 4.9% stake in 10x Genomics, Inc.
02/09/2023 SC 13G/A FMR LLC reports a 8.8% stake in 10X GENOMICS INC
02/08/2023 SC 13G/A MORGAN STANLEY reports a 10.4% stake in 10x Genomics, Inc.
02/01/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/18/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
11/02/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/02/2022 8-K Quarterly results
09/12/2022 SC 13G/A MORGAN STANLEY reports a 10.9% stake in 10x Genomics, Inc.
08/09/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/08/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/08/2022 8-K Quarterly results
08/03/2022 8-K Cost Associated with Exit or Disposal Activities  Interactive Data
07/14/2022 8-K Quarterly results
06/17/2022 8-K Quarterly results
05/09/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
05/05/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/04/2022 8-K Quarterly results
04/29/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/29/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
02/18/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
02/18/2022 10-K Annual Report for the period ended December 31, 2021
02/16/2022 8-K Quarterly results
Docs: "10x Genomics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Outlook for 2022 FY 2021 revenue growth of 64% and Q4 2021 revenue growth of 28% over the corresponding periods of 2020"
02/14/2022 SC 13G/A Venrock Associates VI, L.P. reports a 5.1% stake in 10x Genomics, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy